Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 5/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | FNTA | P49354 | 1/20 | 0.42 |
| ▸ | FNTB | P49356 | 1/20 | 0.42 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 9/20 | 0.41 |
| ▸ | PPARG | P37231 | 7/20 | 0.41 |
| ▸ | PPARD | Q03181 | 7/20 | 0.41 |
| ▸ | PPARA | Q07869 | 7/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TLR2 | O60603 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | FABP4 | P15090 | 2/20 | 0.41 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.41 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1896642 | 1.00 | FFAR4 (0.45) | FFAR4FFAR1TSHRSMN1; SMN2THRB | |
| SCHEMBL1900176 | 1.00 | FFAR4 (0.45) | FFAR4FFAR1TSHRSMN1; SMN2THRB | |
| SCHEMBL1905242 | 1.00 | FFAR4 (0.45) | FFAR4FFAR1TSHRSMN1; SMN2THRB | |
| SCHEMBL1897509 | 0.98 | FFAR4 (0.44) | FFAR4FFAR1TSHRSMN1; SMN2THRB | |
| SCHEMBL1897348 | 0.90 | FNTA (0.49) | FFAR4FFAR1TSHRFNTAFNTB | |
| SCHEMBL9764706 | 0.83 | FFAR4 (0.65) | FFAR4FFAR1TSHRGPR84PPARG | |
| SCHEMBL13724712 | 0.83 | FFAR4 (0.65) | FFAR4FFAR1TSHRGPR84PPARG | |
| SCHEMBL11847071 | 0.83 | FFAR4 (0.65) | FFAR4FFAR1TSHRGPR84PPARG | |
| SCHEMBL1119569 | 0.82 | GPR84 (0.58) | FFAR4FFAR1TSHRTHRBFNTA | |
| SCHEMBL147810 | 0.82 | GPR84 (0.58) | FFAR4FFAR1TSHRTHRBFNTA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2321254-B1 | FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD | EVONIK ROEHM GMBH (DE) | 2014-07-30 | — | — | EP | disclosed |
| EP-2324069-B1 | MONOMER MIXTURE, POLYMER, COATING MEANS AND METHOD FOR PRODUCING A COATING | EVONIK ROEHM GMBH (DE) | 2013-12-18 | — | — | EP | disclosed |
| US-20110144267-A1 | FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD | EVONIK ROEHM GMBH (DE) | 2011-06-16 | — | — | US | disclosed |
| EP-2324069-A1 | MONOMER MIXTURE, POLYMER, COATING MEANS AND METHOD FOR PRODUCING A COATING | Evonik Röhm GmbH (DE) | 2011-05-25 | — | — | EP | disclosed |
| WO-2010026118-A1 | MONOMER MIXTURE, POLYMER, COATING MEANS AND METHOD FOR PRODUCING A COATING | EVONIK RÖHM GMBH (DE) | 2010-03-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144267-A1 | FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD | DNMT1, TET1, MGMT | FFAR4 3162/4885FFAR1 1974/4885TSHR 2023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.